TRAINING

Dr. Hartkoorn obtained a PhD in Pharmacology & Therapeutics (University of Liverpool, UK), and has been a postdoctoral researcher at the University of Liverpool, UK (advisor Prof David Back & Saye Khoo), the École polytechnique fédérale de Lausanne, CH (EPFL, advisor Prof Stewart Cole), and at the University of Geneva (advisor Prof. Dominique Soldati-Favre).
Since 2015 Dr Hartkoorn has become a permeant employee of the French National Institute of Health and Medical Research (INSERM) and started the CBA research team supported through the ATIP-Avenir young researcher program. The CBA team has since developed many innovative research programs tackling antibiotic drug development, programs supported by the ERC (consolidator grant 2019), ATIP-Avenir, ANR (French-German collaborative program 2019), FRM, CPER-CTRL and the SMART-lab.

POSITIONS HELD

DISTINCTIONS / RESPONSIBILITIES

COMPETENCES / EXPERTISE